Barclays (LON:BARC) on Wednesday downgraded the ratings of some U.S. homebuilding stocks DR Horton Inc (NYSE:DHI), Lennar Corporation (NYSE:LEN), PulteGroup Inc (NYSE:PHM) and KB Home (NYSE:KBH) from Overweight to Equal Weight as it expects the rise in new and existing home inventory will lead to flattening home prices and persistently elevated incentives.
Barclays also upgraded Taylor Morrison Home (NYSE:TMHC) Corp to Overweight based on relative valuation and noted that building products&distributors will outperform, as their end markets are nearing a trough.
It also upgraded Owens Corning Inc (NYSE:OC) to Overweight and maintained Overweight ratings for key players including Azek Company Inc (NYSE:AZEK) and Ferguson Enterprises (NYSE:FERG).
“We move to the sidelines on homebuilder stocks entering 2025 but expect building products and distributors to outperform homebuilders and the market, leading us to maintain our Positive industry view,” Barclays said in a note.
For builders, following two years of relative stock outperformance and an unprecedented market recovery despite high interest rates and affordability challenges, Barclays believes the new construction market has now hit a ceiling.
For next year, Barclays forecast that single-family housing starts +2%, multifamily starts -2%, R&R spending +1%, and existing home sales +6%.
Related Articles
Barclays cuts homebuilding stocks on flattening home prices, elevated incentives
Tesla hits record high as post-election surge continues
US charges ex-TD Bank employee with helping to launder money to Colombia
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.